Skip to main content
. Author manuscript; available in PMC: 2014 Nov 1.
Published in final edited form as: Cortex. 2013 Feb 19;49(10):10.1016/j.cortex.2013.02.009. doi: 10.1016/j.cortex.2013.02.009

Table 2.

Comparison of BDNF+/− and BDNF+/+ subjects with WAGR syndrome. Mean ± standard deviation (range) or percentage shown.

BDNF+/− (n=15) BDNF+/+ (n=13) P-Value
Age (y) 15.3 ± 7.4 (6.2–28.3) 14.2 ± 7.9 (6.1–28.3) .71
Sex (% Female) 53.3 69.2 .46
Race/Ethnicity (% Non-Hispanic Caucasian) 93.3 84.6 .36
History of Wilms Tumour (%) 66.7 53.8 .70
Age of Wilms Tumour (y) 2.4 ± 2.1 (.3–7) 2.6 ± 1.6 (1.2–5.5) .88
Visual Acuity Score 4.3 ± 1.4 (3–7) 4.2 ± 1.4 (2–7) .95
Vineland Adaptive Behaviour Composite Score 55 ± 18 (20–82)
(n=15)		 69 ± 10 (46–90)
(n=13)		 .02
Composite IQ/DQ 49 ± 20 (16–84)
(n=13)		 69 ± 25 (16–121)
(n=11)		 .04